Skip to main content
. Author manuscript; available in PMC: 2024 Oct 12.
Published in final edited form as: J Med Chem. 2023 Oct 2;66(19):13821–13837. doi: 10.1021/acs.jmedchem.3c01345

Figure 4.

Figure 4.

Structures of the acylhydrazide (13), hydrazide (14), methyl-1,3,4-oxadiazole (15), monofluoromethyl-1,3,4-oxadiazole (16) and trifluoromethyl-1,3,4-oxadiazole (17) analogs. Inhibitory activities of prepared compounds against HDAC1–4 and HDAC6; IC50 [μM, mean ± SD] or percent inhibition at 10 μM; n.e.: no effect = < 15% inhibition at 10 μM.